Sydney Rosen, MPA

Sydney Rosen, M.P.A., is a Research Professor in the Department of Global Health at the Boston University School of Public Health and a Co-Director of the Health Economics and Epidemiology Research Office (HE2RO) of the University of the Witwatersrand in Johannesburg, South Africa. Her research addresses the economic consequences of the HIV/AIDS epidemic, and in particular the outcomes, costs, cost-effectiveness, and benefits of HIV and TB care and treatment interventions and models of service delivery. She is the principal investigator of multiple USAID-, NIH-, and foundation-supported studies and evaluations in South Africa and has worked extensively in Zambia, Malawi, and Kenya. She is also the author of policy and review papers on the business response to AIDS, the rationing of antiretroviral therapy, and the retention of patients in HIV/AIDS care and treatment programs. Her current projects include AMBIT, EVIDENCE, and EQUIP, all described on the BUSPH website. Professor Rosen’s technical training is in policy analysis and applied economics. She holds a BA magna cum laude from Harvard University and an MPA from the Kennedy School of Government at Harvard.

Co-Division Head
University of the Witwatersrand
Health Economics and Epidemiology Research Office

Retain6: Models of Care for the First 6 months of HIV Treatment
10/12/2021 - 12/31/2024 (PI)
Bill and Melinda Gates Foundation

Evaluation to Inform Decisions using Economics and Epidemiology (The EVIDENCE Project)
01/01/2019 - 11/30/2023 (Subcontract PI)
The Health Economics and Epidemiology Research Office (HE2RO) USAID

Alternative Models of ART Delivery: Optimizing the Benefits (AMBIT)
08/08/2018 - 12/31/2022 (PI)
Bill and Melinda Gates Foundation

EQUIP Years 2-5
10/01/2016 - 09/30/2022 (Subcontract PI)
Right to Care (South Africa) USAID

Improving Pre-ART to improve linkage and retention to care in HIV high burden countries
09/22/2015 - 01/31/2021 (PI)
Bill and Melinda Gates Foundation

The Boston University Clinical HIV/AIDS Research Training Program (BU-CHART)
07/01/2018 - 07/31/2020 (Subcontract PI)
Boston Medical Center Corporation NIH NIAID

INROADS: Innovations Research on HIV/AIDS
01/01/2014 - 12/31/2018 (Subcontract PI)
WITS Health Consortium (PTY) LTD USAID

Rapid Initiation of Antiretroviral Therapy to Promote Early HIV/AIDS Treatment in South Africa (RapIT-SA Study)
06/19/2012 - 05/31/2017 (PI)
NIH/National Institute of Allergy & Infectious Diseases

10/01/2015 - 12/31/2016 (Subcontract PI)
Right to Care (South Africa) USAID

'Associate Award' Costs and Cost Effectiveness of Adult Treatment Delivery in South Africa' under Country Research Activity#GHS-A-00-03-00020-00
01/01/2009 - 12/30/2013 (PI)
U.S. Agency for International Development

Showing 10 of 13 results. Show All Results


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Jamieson L, Rosen S, Phiri B, Grimsrud A, Mwansa M, Shakwelele H, Haimbe P, Mukumbwa-Mwenechanya M, Lumano-Mulenga P, Chiboma I, Nichols BE. How soon should patients be eligible for differentiated service delivery models for antiretroviral treatment? Evidence from a retrospective cohort study in Zambia. BMJ Open. 2022 Dec 22; 12(12):e064070. PMID: 36549722; PMCID: PMC9772670; DOI: 10.1136/bmjopen-2022-064070;
  2. Antoniak S, Chasela CS, Freiman MJ, Stopolianska Y, Barnard T, Gandhi MM, Liulchuk M, Tsenilova Z, Viktor T, Dible J, Wose Kinge C, Akpan F, Minior T, Sigwebela N, Mohamed S, Barralon M, Marange F, Cavenaugh C, Horst CV, Antonyak S, Xulu T, Chew KW, Sanne I, Rosen S. Treatment outcomes and costs of a simplified antiretroviral treatment strategy for hepatitis C among Hepatitis C Virus and Human Immuno deficiency Virus co-infected patients in Ukraine. JGH Open. 2022 Dec; 6(12):894-903. PMID: 36514496; PMCID: PMC9730727; DOI: 10.1002/jgh3.12839;
  3. Guthrie T, Muheki C, Rosen S, Kanoowe S, Lagony S, Greener R, Miot J, Balidawa H, Kiggundu J, Calnan J, Dejene S, Xulu T, Sigwebela N, Long LC. Similar costs and outcomes for differentiated service delivery models for HIV treatment in Uganda. BMC Health Serv Res. 2022 Nov 03; 22(1):1315.View Related Profiles. PMID: 36329450; PMCID: PMC9635081; DOI: 10.1186/s12913-022-08629-4;
  4. Benade M, Long LC, Meyer-Rath G, Miot J, Evans D, Tucker JM, Moultrie H, Rosen S. Reduction in initiations of tuberculosis treatment in South Africa during the COVID pandemic. PLOS Global Public Health. 2022; 2(10):e0000559. View Publication
  5. Benade M, Rosen S, Antoniak S, Chasela C, Stopolianska Y, Barnard T, Gandhi MM, Ivanchuk I, Tretiakov V, Dible J, Minior T, Chew KW, van der Horst C, Tsenilova Z, Sanne I. Impact of direct-acting antiviral treatment of hepatitis C on the quality of life of adults in Ukraine. BMC Infect Dis. 2022 Jul 27; 22(1):650.View Related Profiles. PMID: 35896987; PMCID: PMC9330669; DOI: 10.1186/s12879-022-07615-9;
  6. Benade M, Long L, Rosen S, Meyer-Rath G, Tucker JM, Miot J. Reduction in initiations of HIV treatment in South Africa during the COVID pandemic. BMC Health Serv Res. 2022 Mar 31; 22(1):428.View Related Profiles. PMID: 35361209; PMCID: PMC8970413; DOI: 10.1186/s12913-022-07714-y;
  7. Rosen S, Nichols B, Guthrie T, Benade M, Kuchukhidze S, Long L. Do differentiated service delivery models for HIV treatment in sub-Saharan Africa save money? Synthesis of evidence from field studies conducted in sub-Saharan Africa in 2017-2019. Gates Open Res. 2021; 5:177.View Related Profiles. PMID: 35310814; PMCID: PMC8907143; DOI: 10.12688/gatesopenres.13458.2;
  8. Nichols BE, Rosen S. Economic evaluations of differentiated service delivery should include savings and ancillary benefits, not only health system costs: authors' reply. AIDS. 2021 11 01; 35(13):2235-2236.View Related Profiles. PMID: 34602596; DOI: 10.1097/QAD.0000000000003034;
  9. Maskew M, Brennan AT, Venter WDF, Fox MP, Vezi L, Rosen S. Retention in care and viral suppression after same-day ART initiation: One-year outcomes of the SLATE I and II individually randomized clinical trials in South Africa. J Int AIDS Soc. 2021 10; 24(10):e25825.View Related Profiles. PMID: 34612601; PMCID: PMC8694178; DOI: 10.1002/jia2.25825;
  10. Jo Y, Rosen S, Sy KTL, Phiri B, Huber AN, Mwansa M, Shakwelele H, Haimbe P, Mwenechanya MM, Lumano-Mulenga P, Nichols BE. Changes in HIV treatment differentiated care uptake during the COVID-19 pandemic in Zambia: interrupted time series analysis. J Int AIDS Soc. 2021 10; 24 Suppl 6:e25808.View Related Profiles. PMID: 34713620; PMCID: PMC8554218; DOI: 10.1002/jia2.25808;
Showing 10 of 144 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 144 publications over 22 distinct years, with a maximum of 15 publications in 2021


2019 Boston University School of Public Health: Faculty Award for Excellence in Research and Scholarship
2003 Harvard Business Review: McKinsey Award
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Antiretroviral therapy
Cost-effectiveness analysis
Health economics
South Africa
Same-day ART initiation
Implementation science
Contact for Mentoring:

801 Massachusetts Ave Crosstown Center
Boston MA 02118
Google Map

Rosen's Networks
Click the "See All" links for more information and interactive visualizations
Similar People
Same Department